NIH funding of COVID-19 research in 2020: a cross-sectional study. - 2022

CONCLUSION: In the first year of the pandemic, the NIH diverted a small fraction of its budget to COVID-19 research. Future health emergencies will require research funding to pivot in a timely fashion and funding levels to be proportional to the anticipated burden of disease in the population. Copyright © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. DESIGN: Cross-sectional study. MAIN OUTCOMES AND MEASURES: The primary outcome was to determine the number of grants and funding amount the NIH allocated for COVID-19 by research type and clinical/scientific area. The secondary outcome was to calculate the time from the funding opportunity announcement to the award notice date. OBJECTIVE: This study aims to characterise and evaluate the National Institutes of Health's (NIH's) grant allocation speed and pattern of COVID-19 research. PARTICIPANTS: 1108 grants allocated to COVID-19 research. RESULTS: The NIH awarded a total of 56 169 grants in 2020, of which 2.0% (n=1108) wwas allocated for COVID-19 research. The NIH had a US SETTING: COVID-19 NIH RePORTER Dataset was used to identify COVID-19 relevant grants.


English

2044-6055

10.1136/bmjopen-2021-059041 [doi] bmjopen-2021-059041 [pii] PMC9096053 [pmc]


*Biomedical Research
*COVID-19
COVID-19/ep [Epidemiology]
Cross-Sectional Studies
Financing, Organized
Humans
National Institutes of Health (U.S.)
United States


MedStar Washington Hospital Center


Nursing


Journal Article
Research Support, Non-U.S. Gov't